title: Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin.
abstract: The purpose of this study was to improve the solubility and dissolution rate of sulfamethoxazole (SMZ) with inclusion compound of β-cyclodextrin (β-CD). The interaction between SMZ and β-CD in solution was studied by the phase-solubility method. The phase-solubility studies revealed the formation of inclusion complexes with poor solubility with an inclusion complex of 1:1 molar ratio and a stability constant of 122.3 M(-1). The solid complexes of SMZ with β-CD were prepared by using kneading and coprecipitation methods. The physical mixture of these chemicals was also prepared for comparison. Inclusion complexation was confirmed by the results from the studies of infrared spectoroscopy (IR) and differential scanning calorimetry (DSC). The effect of water-soluble polymers i.e., polyethylene glycol 20000 and non-ionic surfactants i.e., polysorbate 20 on the complexation of SMZ with β-CD was also investigated by the same methods. The rates of release of the active material from the complexes were determined from dissolution studies using USP XXII paddle method. The formulation, that provided delivery of active material near to the target value in six healthy volunteers and in vivo tests, clearly revealed that the bioavailability of active material was found to be enhanced by preparing ternary mixtures.
authors: Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ankara, Tandoğan-Ankara, Turkey. nozdemir@pharmacy.ankara.edu.tr
authors: Nurten
authors: N
authors: Ozdemir
authors: Jülide
authors: J
authors: Erkin
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000737:chemistry / Q000493:pharmacokinetics*; D001682:Biological Availability; D002152:Calorimetry, Differential Scanning; D004339:Drug Compounding; D016503:Drug Delivery Systems; D006801:Humans; D008297:Male; D008875:Middle Aged; D012995:Solubility; D013055:Spectrophotometry, Infrared; D013420:Sulfamethoxazole / Q000737:chemistry / Q000493:pharmacokinetics*; D013997:Time Factors; D047392:beta-Cyclodextrins / Q000737:chemistry*
chemical_list: D000890:Anti-Infective Agents; D047392:beta-Cyclodextrins; D013420:Sulfamethoxazole